Progestin-containing drug delivery system

Details for Australian Patent Application No. 2009279053 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors General, Sascha; Terebesi, Ildiko; Bracht, Stefan; Funke, Adrian

Agent Davies Collison Cave

Pub. Number AU-A-2009279053

PCT Pub. Number WO2010/015713

Priority 61/087,334 08.08.08 US; 08162105.4 08.08.08 EP; PCT/ EP2009/000904 10.02.09 EP

Filing date 7 August 2009

Wipo publication date 11 February 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2010/015713 Priority application(s): WO2010/015713

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009279062-Cells producing glycoproteins having altered glycosylation patterns and methods and use thereof

2009278998-Improvement to the bayer process for producing alumina trihydrate, said process comprising a step in which the supersaturated liquor is filtered at high temperature before decomposition